Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Product News: The Liposome Company

Executive Summary

The Liposome Company: Sales of Abelcet in the U.S. and overseas have exceeded $6 mil. so far in 1996, Princeton, N.J.-based firm says. "The launch of Abelcet has been extremely well received by physicians in the U.S." with "about 80% of the 50 hospitals that are the largest users of amphotericin B" buying the liposomal amphotericin formulation since its mid-December launch, TLC maintains. The company released the figures because it "is concerned about inaccurate information in the investment community concerning Abelcet and its sales prospects"...
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS027766

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel